Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 70Neoplasms 7Neoplasm Metastasis 5Advanced Breast Cancer 5Carcinoma, Intraductal, Noninfiltrating 3Breast Carcinoma In Situ 3Neoplasms by Site 2Breast Neoplasms, Male 2Breast Diseases 2Skin Diseases 1Recurrence 1Quality of Life 1Low Grade Serous Ovarian Cancer 1Hormone Receptor-Positive and HER2-Negative Advanced Breast Cancer 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Camurati-Engelmann Syndrome 1Breast Neoplasm Female 1Breast Cancer Metastatic 1Breast Cancer Female 1Bone Density 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Metastatic Breast Cancer 1

Interventions

Radiotherapy 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Camurati-Engelmann Syndrome × Anastrozole × Clear all
NCT01402193 2014-06-25

Study of Arimidex and Radiotherapy Sequencing

Fudan University

Phase 3 Unknown
220 enrolled
Breast

Breast Neoplasms, Camurati-Engelmann Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡